about
Anti-angiogenic therapy for lung cancerA transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotypePhase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer.Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs.Evaluation of results of linac-based radiosurgery for brain metastases from primary lung cancer.Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancerPrognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancerEpidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.New approaches for small-cell lung cancer: local treatments.A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.Aberrant LRP16 protein expression in primary neuroendocrine lung tumors.Drug rechallenge and treatment beyond progression--implications for drug resistance.Surgical intervention for small-cell lung cancer: what is the surgical role?Chemoprevention of lung cancer: concepts and strategies.A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population.Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center.Small cell lung cancer: treatment review.Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.Targeted therapies in small-cell lung cancer.Further understanding of an uncommon disease of combined small cell lung cancer: clinical features and prognostic factors of 114 cases.A microRNA-related single nucleotide polymorphism of the XPO5 gene is associated with survival of small cell lung cancer patients.Combination of HDAC and topoisomerase inhibitors in small cell lung cancer.Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer.A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung CancerComparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.Surgical treatment of early stage small cell lung cancer.Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.[99mTc-octreotide receptor scintigraphy in NCI-H446 small cell lung cancer nude mice model].Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.
P2860
Q24240857-AC973B9A-AE68-48B2-9DD4-1C5B49EB0CA0Q33201186-D20A3262-2438-4848-8F5B-A84534FD354CQ33370887-3C895272-7505-47BD-AE6C-6546AB87967DQ33412801-121A52D5-728E-46D1-8721-41301F1AC41DQ33437893-E66DA31B-9E80-4FBF-9A07-EB6D76B14650Q33751488-805C5CF3-558A-465E-9A50-F892E9299640Q33817153-9186E0DD-9302-41BE-AFED-440204CACA66Q34419020-A1867B6A-88EB-414B-B866-2D121C4382CBQ34676580-0E750DEA-54AD-4717-9578-31971539B33BQ34964303-1EB4D3AA-FE7E-4D9E-B7D9-9C84F48C25F8Q35136043-FD8FFC78-4B1C-4AAC-A803-C101C129084CQ35198443-C13C153C-4815-4750-A04E-070BA72974CBQ35746318-0F9C4305-9E12-4CB1-A199-A9825F537744Q35870332-19F7E2C5-952C-4D17-9F9C-7B9762AE40C1Q35919043-EADBE48C-47A3-470E-9068-EF7DA60465DAQ35967416-676BECBF-40D3-468E-A725-C7CFB42F1AF5Q36072024-ECDA1B36-EEB8-47AC-93B7-6E87075E7453Q36185641-7756C948-2374-46F7-B1EE-A7919ED3CE98Q36224408-190977BF-DD59-4B6C-BAE2-E054E73B6EBFQ36265194-2BD420DF-1BC5-45C1-A28E-9674323938B6Q36297434-4143C4F9-5095-4462-98EC-8A8A3D81BBADQ36318066-C31D0477-F095-42DE-A9FC-2230108D2DEDQ36421105-386DDCAE-7F5C-4159-AC09-661711CD4C81Q36458604-72B525D4-4C01-4467-8318-C376393F0191Q36464730-BFEFB69B-ED19-4F7E-86E6-827DC728A81AQ36740205-3A6AB26D-594D-4F53-A388-10F7BE473506Q36897340-0E3DB831-483E-4C64-AEE9-AE14D749F20BQ37402093-A00806B5-7CAD-44CB-9D91-25B3832F2BDBQ37565272-79B07B4B-932B-4CB4-A739-926A473237CEQ39375125-6A4C4525-1EB1-452E-9904-139B6B9C4E47Q39412383-C8D1D654-A953-445B-B076-37604BF3E747Q40153342-5642CD35-BF25-41A4-8E7B-DA2ECFEE5BD3Q41860470-D1902D09-ADC4-4618-9105-881B2B74C1C4Q45200343-7C200DCE-8238-40E8-AB2E-AE6C65A61CD9Q45217486-C32A871D-5EFF-4008-8B57-BDAC15A8AEF5Q50882852-EBA8C0B6-513D-418B-9CBE-850A72D9FE9BQ51794356-E38F5C8B-B709-48C6-A548-BF033497B4ECQ53149549-BB4A6753-1515-4818-B67B-17BE25DAEA98Q53633587-32F10F20-955E-4609-A823-F6D1263D5558Q54667529-F54E5622-6C05-4E22-A348-88A096496F7E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Small cell lung cancer.
@ast
Small cell lung cancer.
@en
type
label
Small cell lung cancer.
@ast
Small cell lung cancer.
@en
prefLabel
Small cell lung cancer.
@ast
Small cell lung cancer.
@en
P1433
P1476
Small cell lung cancer.
@en
小細胞肺癌。
@zh
P2093
George R Simon
Henry Wagner
P304
P356
10.1378/CHEST.123.1_SUPPL.259S
P407
P433
P577
2003-01-01T00:00:00Z